# Clinical Study Evaluating the Performance of HEMOBLAST Bellows Compared to FLOSEAL Hemostatic Matrix in Cardiothoracic Operations

> **NCT03725098** · NA · COMPLETED · sponsor: **Biom'Up France SAS** · enrollment: 105 (actual)

## Conditions studied

- Cardiothoracic Surgery

## Interventions

- **DEVICE:** HEMOBLAST Bellows
- **DEVICE:** FLOSEAL

## Key facts

- **NCT ID:** NCT03725098
- **Lead sponsor:** Biom'Up France SAS
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-01
- **Primary completion:** 2019-06-28
- **Final completion:** 2019-06-28
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2020-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03725098

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03725098, "Clinical Study Evaluating the Performance of HEMOBLAST Bellows Compared to FLOSEAL Hemostatic Matrix in Cardiothoracic Operations". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03725098. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*